Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Kentucky
Northwestern University
Northwestern University
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Fred Hutchinson Cancer Center